Importance of dose and dose intensity in the treatment of small-cell lung cancer

Cancer Chemotherapy and Pharmacology, Supplement

Volumn 40, Issue , 1997, Pages

  Murray, Nevin ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Chemotherapy; Dose intensity; Small cell lung cancer

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERFERON; TAMOXIFEN; VINCRISTINE;

ANIMAL MODEL; CHEMOTHERAPY; CONFERENCE PAPER; DOSE RESPONSE; DRUG EFFICACY; HUMAN; IRRADIATION; LUNG SMALL CELL CANCER; PRIORITY JOURNAL;

EID: 0030835329     PISSN: 09439404     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002800051063     Document Type: Conference Paper

References (18)

1. Arriagada R, Le Chevalier T, Pignon JP, Riviere A, Monnet I, Chomy P, Tuchais C, Taraye M, Ruffie P (1993) Initial chemotherapeutic doses and survival in patients with limited small-cell lung cancer. N Engl J Med 329:1848
2. Cohen MH, Creaven PJ, Fossieck BE, Broder LE, Selawry OS, Johnston AV, Williams CL, Minna JD (1977) Intensive chemotherapy of small cell bronchogenic carcinoma. Cancer Treat Rep 61:394
3. Coldman A (1990) Dose intensive chemotherapy and the development of resistance to anticancer agents. In: Kimura D, Yamada K, Carter SK (eds) Cancer chemotherapy: challenges for the future, vol 5. Excerpta Medica, Tokyo, p 41
4. Coppin C (1987) The description of chemotherapy delivery: options and pitfalls. Semin Oncol 14:34
5. Elias A (1997) Dose-intensive therapy in lung cancer. Cancer Chemother Pharmacol 40 (Suppl):S64-S69
6. Figueredo AT, Hryniuk WM, Strautmanis I, Frank G, Rendell S (1985) Co-trimoxazole prophylaxis during high-dose chemotherapy of small-cell lung cancer. J Clin Oncol 3:54
7. Furuse K, Kubota K, Nishiwaki Y, Takada M, Kurita Y, Watanabe K, Noda M, Fukuoka M, Ariyoshi H, Osaki Y, Tamura H, Saigo N (1996) Phase III study of dose intensive weekly chemotherapy with recombinant human granulocyte-colony stimulating factor (G-CSF) versus standard chemotherapy in extensive stage small cell lung cancer (SCLC). Proc Am Soc Clin Oncol 15:375 (abstract)
8. Goldie JG, Coldman AJ (1979) A mathematical model for relating the drug sensitivity of tumors to their spontaneous mutation rate. Cancer Treat Rep 63:1727
9. Hande KR, Oldham RK, Mehmet FF, Richardson RL, Greco FA (1982) Randomized study of high-dose versus low-dose methotrexate in the treatment of extensive small cell lung cancer. Am J Med 73:413
10. Ihde DC, Mulshine JL, Kramer BS, Steinberg SM, Linnoila RI, Gazdar AF, Edison M, Phelps RM, Lesar M, Phares JC, Grayson J, Minna J, Johnson B (1994) Prospective randomized comparison of high-dose and standard-dose etoposide and cisplatin chemotherapy in patients with extensive-stage small-cell lung cancer. J Clin Oncol 12:2022
11. Johnson DH, Einhorn LH, Birch R, Vollmer R, Perez C, Krauss S, Omura G, Greco FA (1987) A randomized comparison of high-dose versus conventional-dose cyclophosphamide, doxorubicin, and vincristine for extensive-stage small-cell lung cancer: a phase III trial of the Southeastern Cancer Study Group. J Clin Oncol 5:1731
12. Klasa RJ, Murray N, Coldman AJ (1991) Dose-intensity meta-analysis of chemotherapy regimens in small-cell carcinoma of the lung. J Clin Oncol 9:499
13. Mehta C, Vogl SE (1982) High-dose cyclophosphamide in the induction therapy of small cell lung cancer: minor improvements in rate of remission and survival. Proc Am Assoc Cancer Res 23:155
14. Murray N, Shah A, Hadzic E, Band P, Voss N, Van den Hoek J, Murphy K, Sparling T, Noble M (1984) Alternating chemotherapy and thoracic irradiation with concurrent cisplatin-etoposide for limited stage small cell lung cancer. Proc Am Soc Clin Oncol 3:214
15. Murray N, Shah A, Osoba D, Page R, Karsai H, Grafton C, Goddard K, Fairey R, Voss N (1991) Intensive weekly chemotherapy for the treatment of extensive-stage small-cell lung cancer. J Clin Oncol 9:1632
16. Schabel FM Jr, Griswold DP Jr, Corbett TH, Laster WR Jr, Mayo JG, Lloyd HH (1979) Testing therapeutic hypotheses in mice and man: observations on the therapeutic activity against advanced solid tumors of mice treated with anticancer drugs that have demonstrated or potential clinical utility for treatment of advanced solid tumors of man. In: DeVita V Jr, Busch H (eds) Cancer drug development, part B. Methods in cancer research, vol 17. Academic Press, New York, p 3
17. Schabel FM Jr, Griswold DP Jr, Corbett TH, Laster WR Jr (1984) Increasing the therapeutic response rates to anticancer drugs by applying the basic principles of pharmacology. Cancer 54:1160
18. Skipper HE (1990) Dose intensity versus total dose of chemotherapy: an experimental basis. In: DeVita V, Hellman S, Rosenberg S (eds) Important advances in oncology. Lippincott, Philadelphia, p 43